4.2 Article

Sec13 is a positive regulator of VISA-mediated antiviral signaling

Journal

VIRUS GENES
Volume 54, Issue 4, Pages 514-526

Publisher

SPRINGER
DOI: 10.1007/s11262-018-1581-0

Keywords

Sec13; VISA/MAVS; RLR antiviral signaling; Interferon; IRF3

Funding

  1. National Natural Science Foundation of China [31370876, 31570876]
  2. Natural Science Foundation of Jiangxi Province [20143ACB20004, 20161BAB204177]
  3. Open Project Program of Key Laboratory of Functional Small Organic Molecule, Ministry of Education [KLFS-KF-201407]
  4. Jiangxi Normal University [2014A]
  5. Open Project Program of Key Laboratory of Functional Small Organic Molecule, Jiangxi Normal University [KLFS-KF-201407]

Ask authors/readers for more resources

Viral infection triggers the innate antiviral immune response that rapidly produces type I interferons in most cell types to combat viruses invading. Upon viral infection, the cytoplasmic RNA sensors RIG-I/MDA5 recognize viral RNA, and then RIG-I/MDA5 is transported to mitochondria interacting with VISA through the CARD domain. From there, VISA recruits downstream antiviral signaling pathways molecules, such as TRAFs and TBK1. Eventually, IRF3 is phosphorylated and type I IFNs are induced to fight as the first line of defense against viruses. However, it remains unclear how VISA acts as a scaffold to assemble the signalosome in RIG-I-mediated antiviral signaling. Here, we demonstrated Sec13 as a novel component that was involved in VISA-mediated antiviral signaling pathway. The co-immunoprecipitation assays showed that Sec13 specifically interacts with VISA. Overexpression of Sec13 increases VISA's aggregation and ubiquitination and significantly enhances the phosphorylation and dimerization of IRF3, facilitating the IFN-beta production. Conversely, the knockdown of Sec13 attenuates Sendai virus-induced and VISA-mediated IRF3 activation and the production of IFN beta, thus weakens antiviral immune activity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available